Dr. Jafar is a tenured Professor in the Program of Health Services & Systems Research at Duke-NUS Medical School in Singapore, Visiting Consultant, Renal Medicine, Singapore General Hospital, and Professor of Global Health Duke Global Health Institute, Durham USA.
Professor Jafar is globally renowned for leading large impactful multi-country trials including the COBRA-BPS (Control of Blood Pressure and Risk Attenuation – Bangladesh, Pakistan, Sri Lanka) study published in NEJM https://www.nejm.org/doi/10.1056/NEJMoa1911965?url+_.
Prof Jafar is the recipient of the senior clinical scientist award from the Singapore National Medical Research Council and leads the innovative SingHypertension cluster RCT for improving the management of hypertension in Singapore polyclinics. She is also the theme PI on the A*STAR funded "Diabetes Clinic of the Future" program in Singapore.
Prof Jafar is a member of the MRC Applied Global Health Research Board and serves on several national and international research funding panels, and advisory committees of research and regulatory agencies.
Session:
Continuum & Community, 7 October 2022, 1415 - 1615hrsScaling-up Low Cost Solutions to Improve Hypertension Care Globally
Return to Speakers >